FDA announced the availability of Final Guideline for Industry on presenting quantitative efficacy and risk information in...

FDA is proposing to amend its drug product labeling rules for Medication Guide and other information templates provided to...

March 29, 2023 Recent update by #FDA: #Face-to-Face Meetings are back for ANDAs: The FDA's generic drug program will restart holding...